Allograft
-
Biologics
Kolosis BIO and MTF Biologics Announce Launch of Kore Fiber™
February 17, 2021 SALT LAKE CITY–(BUSINESS WIRE)–Kolosis BIO, LLC (Kolosis) announced today, in collaboration with MTF Biologics (MTF), the market…
Read More » -
Biologics
ViviGen® Cellular Bone Matrix outperforms MSC-based allografts and is equivalent to gold standard autograft
VIRGINIA BEACH, Va., Dec. 29, 2020 /PRNewswire/ — ViviGen® Cellular Bone Matrix — the first cellular allograft to recover and protect viable, lineage-committed bone…
Read More » -
Biologics
Science Behind AlloSource’s Cryopreserved Cartilage Published In Journal Of Orthopaedic Surgery And Research
CENTENNIAL, Colo., Dec. 8, 2020 /PRNewswire/ — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products…
Read More » -
Biologics
SeaSpine Announces Publication of Results from a Cellular Bone Graft Study in The Journal of Bone and Joint Surgery (JBJS)
CARLSBAD, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Biologics
Orthofix Launches O-GENESIS Graft Delivery System and New Hydrated, Ready-to-Use AlloQuent Structural Allograft Q-PACK
October 7, 2020 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus,…
Read More » -
Recon
HSS Study: Good Outcomes After Arthroscopic Shoulder Superior Capsular Reconstruction
by Elizabeth Hofheinz, M.P.H., M.Ed. A group of researchers from Hospital for Special Surgery (HSS) in New York has explored…
Read More » -
Biologics
AlloSource® Names Tendon And Ligament Portfolio Under New Brand AlloConnex™
CENTENNIAL, Colo., July 23, 2020 /PRNewswire/ — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue allografts…
Read More » -
Biologics
Spine Wave Announces the Commercial Launch of Tempest® Allograft Bone Matrix
SHELTON, Conn., July 14, 2020 (GLOBE NEWSWIRE) — Spine Wave is pleased to announce the successful completion of a limited…
Read More » -
Biologics
Novel Tissue Preservation Method Improves Outcomes in Cartilage Transplant Procedures in the Knee
COLUMBIA, Mo. (July 8, 2020) ― A University of Missouri study on clinical outcomes after biologic knee restoration surgery found…
Read More » -
Biologics
Cerapedics Announces Results from Clinical Trial of i-FACTOR® Peptide Enhanced Bone Graft in Lumbar Fusion Surgery
WESTMINSTER, Colo., May 19, 2020 /PRNewswire/ — Cerapedics, a private ortho-biologics company, today announced that results from a clinical trial evaluating i-FACTOR Peptide…
Read More » -
Biologics
Organogenesis Announces Virtual Education Events for April
CANTON, Mass., April 13, 2020 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development,…
Read More » -
OSN Premium
Philadelphia Eagles Surgeon Talks ACL Grafts, Biologics
by Elizabeth Hofheinz, M.P.H., M.Ed., March 4, 2020 Dr. Christopher Dodson, M.D. Christopher Dodson, M.D., an orthopedic surgeon at The…
Read More » -
Biologics
Integra LifeSciences Launches AmnioExcel® Plus Placental Allograft Membrane – The Next Generation in Amniotic Tissue Products
PRINCETON, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) — Integra LifeSciences Holding Corporation (Nasdaq:IART), a leading global medical technology company, today announced the…
Read More » -
Biologics
Royal Biologics announces the launch of MAGNUS, a DMSO-free viable cellular bone allograft
JANUARY 08, 2020 Royal Biologics, an ortho-biologics company specializing in the research and advancement of regenerative cellular therapy and novel…
Read More » -
Extremities
Introducing the New AlloAid BioNail Implant
December 10, 2019 MEMPHIS, Tenn.–(BUSINESS WIRE)–In2Bones Global, Inc. today announced the global launch of the AlloAid BioNail™, an engineered, sterile allograft implant…
Read More »